Regulatory Updates, Annex 1 & Sterile Manufacturing Training & Top Tips for Compliant Patient Information Leaflets (PILs) We’ve had a busy start to 2026, delivering a wide range of GMP and GDP training to organisations across the industry. This newsletter…
𝗕𝗲𝘀𝘁 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲𝘀 & 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 – 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝟱𝘁𝗵 𝗠𝗮𝗿𝗰𝗵 EPiC is pleased to highlight an upcoming webinar hosted by the Research Quality Association (RQA), designed for professionals involved in clinical trial operations, IMP oversight, and regulatory compliance. This comprehensive session…
Regulatory Updates, GCP Training Courses & QP Excellence Top Tips In this EPiC Update, we start the year by focusing on what matters most: robust GXP compliance, clear regulatory understanding, and practical support for the professionals driving quality across the…
Regulatory Updates, On-Demand Learning & New Opportunities This edition is packed with insights and opportunities for professionals across the pharmaceutical and healthcare sectors. Inside, you’ll find: Stay informed, explore new opportunities, and connect with EPiC’s expanding network of experts. WHAT…
EPiC Auditors Autumn Compliance Seminar: Thursday 10th November 2022 Here’s what our speakers have to say about the pharma compliance event; “How to achieve Regulatory compliance for small, new and innovative companies can seem an impossible task. How to maintain pharma…
With just over 3 weeks to go until the EPiC Autumn Pharma Compliance Seminar on Thursday 10th November 2022 we have released a copy of the whole day’s agenda. Here’s a summary of what is covered: Download the Agenda here:…
MHRA Inspectorate Blog has recently published Part 2 in the Compliance Monitor Process series with further information about the Compliance Monitor (CM) role and application process. The blog can be found here: Compliance Monitor Process (Part 2)– CM role and…
At EPiC, post-inspection remediation is a core element of our GXP compliance consultancy service. Many of EPiCs consultants have experience of MHRA Compliance Management team (CMT) and Inspection Action Group (IAG) processes, gained working within the MHRA and also outside…
We are very pleased to announce that Michelle Yeomans, GMDP Inspectorate Unit Manager at the MHRA will be delivering a Regulatory Update at the forthcoming GMP symposium. Michelle will be covering the Clinical Trials Regulation and what it means to…